Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Adler

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|February 6, 2004
Docking of endothelial nitric oxide synthase (eNOS) to the mitochondrial outer membrane: a pentabasic amino acid sequence in the autoinhibitory domain of eNOS targets a proteinase K-cleavable peptide on the cytoplasmic face of mitochondriaShujuan Gao, Jun Chen, Sergey V Brodsky, et al.
Oncotarget|March 11, 2015
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imagingLiza Lindenberg, Anish Thomas, Stephen Adler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018
Biodistribution, Tumor Detection, and Radiation Dosimetry of <sup>18</sup>F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid TumorsColin R Young, Stephen Adler, Janet F Eary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2011
Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CTKaren A Kurdziel, Joseph D Kalen, Jerry I Hirsch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2014
[¹⁸F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ 3 and α vβ 5 integrinsEsther Mena, Rikard Owenius, Baris Turkbey, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HClSharon M Moe, John Cunningham, Jürgen Bommer, et al.
Radiology|January 31, 2014
Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysisBaris Turkbey, Esther Mena, Joanna Shih, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 30, 2023
Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft ModelShan Huang, Ling Ren, Jessica A Beck, et al.
Neoplasia (New York, N.Y.)|October 8, 2025
Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Metabolic and imaging phenotypes associated with <i>RB1</i> and <i>TP53</i> loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|February 6, 2004
Docking of endothelial nitric oxide synthase (eNOS) to the mitochondrial outer membrane: a pentabasic amino acid sequence in the autoinhibitory domain of eNOS targets a proteinase K-cleavable peptide on the cytoplasmic face of mitochondriaShujuan Gao, Jun Chen, Sergey V Brodsky, et al.
Oncotarget|March 11, 2015
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imagingLiza Lindenberg, Anish Thomas, Stephen Adler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018
Biodistribution, Tumor Detection, and Radiation Dosimetry of <sup>18</sup>F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid TumorsColin R Young, Stephen Adler, Janet F Eary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2011
Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CTKaren A Kurdziel, Joseph D Kalen, Jerry I Hirsch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2014
[¹⁸F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ 3 and α vβ 5 integrinsEsther Mena, Rikard Owenius, Baris Turkbey, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HClSharon M Moe, John Cunningham, Jürgen Bommer, et al.
Radiology|January 31, 2014
Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysisBaris Turkbey, Esther Mena, Joanna Shih, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 30, 2023
Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft ModelShan Huang, Ling Ren, Jessica A Beck, et al.
Neoplasia (New York, N.Y.)|October 8, 2025
Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Metabolic and imaging phenotypes associated with <i>RB1</i> and <i>TP53</i> loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Pageof 5